Bone Loss in Melanoma Survivors Receiving Immunotherapy

Clinical trial NCT04516122 · TERMINATED

Trial details

NCT number: NCT04516122
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Study type: OBSERVATIONAL

Clinical Stage III Cutaneous Melanoma AJCC v8 Clinical Stage IV Cutaneous Melanoma AJCC v8 Pathologic Stage III Cutaneous Melanoma AJCC v8 Pathologic Stage IIIA Cutaneous Melanoma AJCC v8 Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Pathologic Stage IIID Cutaneous Melanoma AJCC v8 Pathologic Stage IV Cutaneous Melanoma AJCC v8

Start date: 2021-05-10
Primary completion: 2025-06-18
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.